290
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii

, , &
Pages 1171-1180 | Published online: 13 May 2019

References

  • Ghajavand H, Esfahani BN, Havaei SA, Moghim S, Fazeli H. Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns. Adv Biomed Res. 2015;4:110.26261812
  • Hanlon GW. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol. 2005;41(5):375–378. doi:10.1111/j.1472-765X.2005.01791.x16238638
  • Gillings MR. Integrons: past, present, and future. Microbiol Mol Biol Rev. 2014;78(2):257–277. doi:10.1128/MMBR.00056-1324847022
  • Martins N, Picão RC, Adams-Sapper S, Riley LW, Bm M. Association of class 1 and 2 integrons with multidrug-resistant Acinetobacter baumannii international clones and Acinetobacter nosocomialis isolates. Antimicrob Agents Chemother. 2015;59(1):698–701. doi:10.1128/AAC.02415-1425348522
  • Huang C, Long Q, Qian K, et al. Resistance and integrin characterization of Acinetobacter baumannii in a teaching hospital in Chongqing, China. New Microbes New Infect. 2015;8:103–108. doi:10.1016/j.nmni.2015.09.01526649184
  • Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis. 2003;37(2):214–220. doi:10.1086/37587512856214
  • Tsakris A, Poulou A, Kristo I, et al. Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections. J Clin Microbiol. 2009;47(11):3524–3529. doi:10.1128/JCM.01099-0919776233
  • Bebrone C. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol. 2007;74(12):1686–1701. doi:10.1016/j.bcp.2007.05.02117597585
  • Khosravi Y, Tay ST, Vadivelu J. Analysis of integrons and associated gene cassettes of metallo-β-lactamase-positive Pseudomonas aeruginosa in Malaysia. J Med Microbiol. 2011;60(Pt7):988–994. doi:10.1099/jmm.0.029868-021436370
  • Anoar KA, Ali FA, Omer SA. Detection of metallo [Beta]-lactamase enzyme in somegram negative bacteria isolated from burn patients in Sulaimani city, Iraq. Eur Sci J. 2014;10(3):485–496.
  • Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother. 2007;60(2):1206–1215. doi:10.1093/jac/dkm35717878146
  • Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother. 1999;33(9):960–967. doi:10.1345/aph.1842610492501
  • Hall GS. Non-fermenting and miscellaneous gram-negative bacilli In: Mahon CR, Lehman DC, Manuselis G, Heights M, editors. Textbook of Diagnostic Microbiology. 4th ed. Mo: Saunders/Elsevier; 2011:482–501.
  • Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44:2974–2976. doi:10.1128/JCM.01021-0616891520
  • CLSI. M100-S28. Performance standards for antimicrobial susceptibility testing; Twenty-eight informational supplement; 2018.
  • Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010;2(3):291–304. doi:10.4103/0974-777X.6853820927292
  • Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40(10):3798–3801.12354884
  • Tavakol M, Momtaz H, Mohajeri P, Shokoohizadeh L, Tajbakhsh E. Genotyping and distribution of putative virulence factors and antibiotic resistance genes of Acinetobacter baumannii strains isolated from raw meat. Antimicrob Resist Infect Control. 2018;7:120. doi:10.1186/s13756-018-0405-230323923
  • Koeleman JGM, Stoof J, Van Der Bijl MW, Cmje V-G, Savelkoul PHM. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol. 2001;39(1):8–13. doi:10.1128/JCM.39.1.8-13.200111136740
  • Fallah F, Noori M, Hashemi A, et al. Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM Genes among Acinetobacter baumannii Isolated from Two Hospitals of Tehran, Iran. Scientifica (Cairo). 2014;245162.25133013
  • Aksoy MD, Çavuşlu Ş, Tuğrul HM. Investigation of Metallo Beta lactamases and oxacilinases in carbapenem resistant Acinetobacter baumannii strains isolated from inpatients. Balkan Med J. 2015;32(1):79–83. doi:10.5152/balkanmedj.2015.1530225759776
  • Mlynarcik P, Roderova M, Kolar M. Primer evaluation for PCR and its application for detection of carbapenemases in enterobacteriaceae. Jundishapur J Microbiol. 2016;9(1):e29314. doi:10.5812/jjm27099689
  • Moura A, Henriques I, Ribeiro R, Correia A. Prevalence and characterization of integrons from bacteria isolated from a slaughterhouse wastewater treatment plant. J Antimicrob Chemother. 2007;60(6):1243–1250. doi:10.1093/jac/dkm34017913715
  • Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–1874. doi:10.1093/molbev/msw05427004904
  • Gaynes R, Edwards JR. National nosocomial infections surveillance system. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41(6):848–854. doi:10.1086/44449916107985
  • Banerjee T, Mishra A, Das A, Sharma S, Barman H, Yadav G. High prevalence and endemicity of multidrug resistant Acinetobacter spp. in intensive care unit of a tertiary care Hospital, Varanasi, India. J Pathog. 2018;2018:9129083. doi:10.1155/2018/912908330057820
  • Begum S, Hasan F, Hussain S, Ali Shah A. Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan. Pak J Med Sci. 2013;29(5):1253–1258.24353731
  • De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. J Infect Public Health. 2013;6(3):179–185. doi:10.1016/j.jiph.2012.11.00623668462
  • Tuan Anh N, Nga TV, Tuan HM, et al. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern VIETNAM. J Med Microbiol. 2017;66(1):46–53. doi:10.1099/jmm.0.00041828198682
  • Shrestha S, Tada T, Miyoshi-Akiyama T, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage. Int J Antimicrob Agents. 2015;46(5):526–531. doi:10.1016/j.ijantimicag.2015.07.01226362951
  • Castilho SRA, Godoy CSM, Guilarde AO, et al. Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: molecular and drug susceptibility profiles. PLoS One. 2017;12(5):e0176790. doi:10.1371/journal.pone.017679028475585
  • Shoja S, Moosavian M, Rostami S, et al. Dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injuries. J Chin Med Assoc. 2017;80(4):245–252. doi:10.1016/j.jcma.2016.10.01328268175
  • Mirnejad R, Mostofi S, Masjedian F. Antibiotic resistance and carriage class 1and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran,Iran. Asian Pac J Trop Biomed. 2013;3(2):140–145. doi:10.1016/S2221-1691(13)60038-623593593
  • Taherikalani M, Fatolahzadeh B, Emaneini M, Soroush S, Mm F. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 2009;32(3):265–271.19845108
  • Najar Peerayeh S, Karmostaji A. Molecular identification of resistance determinants, integrons and genetic relatedness of extensively drug resistant Acinetobacter baumannii isolated from hospitals in Tehran, Iran. Jundishapur J Microbiol. 2015;8(7):e27021. doi:10.5812/jjm26421140
  • Bahador A, Taheri M, Pourakbari B, et al. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist. 2013;19(5):397–406. doi:10.1089/mdr.2012.023323768166
  • Aliakbarzade K, Farajnia S, Karimi Nik A, Zarei F, Tanomand A. Prevalence of aminoglycoside resistance genes in Acinetobacter baumannii isolates. Jundishapur J Microbiol. 2014;7(10):e11924. doi:10.5812/jjm.1192425632323
  • Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol. 2013;5(3):195–202.24475323
  • Genteluci GL, Gomes DB, Souza MJ, Carvalho KR, Villas-Bôas MH. Emergence of polymyxin B-resistant Acinetobacter baumannii in hospitals in Rio de Janeiro. J Bras Patol Med Lab. 2016;52(2):91–95.
  • Lee K, Yum JH, Yong D, et al. Novel acquired metallobeta- lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother. 2005;49(11):4485–4491. doi:10.1128/AAC.49.11.4485-4491.200516251286
  • Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011;3(2):68–74.22347585
  • Ikonomidis A, Ntokou E, Maniatis AN, Tsakris A, Pournaras S. Hidden VIM-1 metallobeta-lactamase phenotypes among Acinetobacter baumannii clinical isolates. J Clin Microbiol. 2008;46(1):346–349. doi:10.1128/JCM.01670-0718032624
  • Ramírez MS, Stietz MS, Vilacoba E, et al. Increasing frequency of class 1 and 2 integrons in multidrug-resistant clones of Acinetobacter baumannii reveals the need for continuous molecular surveillance. Int J Antimicrob Agents. 2011;37(2):175–177. doi:10.1016/j.ijantimicag.2010.10.00621177078
  • Japoni S, Japoni A, Farshad S, Ali AA, Jamalidoust M. Association between existence of integrons and multi-drug resistance in Acinetobacter isolated from patients in southern Iran. Pol J Microbiol. 2011;60(2):163–168.21905635
  • Tsakris A, Ikonomidis A, Pournaras S, et al. VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg Infect Dis. 2006;12(6):981–983.16707056
  • Mendes RE, Castanheira M, Toleman MA, Sader HS, Jones RN, Walsh TR. Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6‘)-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital. Antimicrob Agents Chemother. 2007;51(7):2611–2614. doi:10.1128/AAC.00838-0617470660
  • Goudarzi H, Azad M, Seyedjavadi SS, et al. Characterization of integrons and associated gene cassettes in Acinetobacter baumannii strains isolated from intensive care unit in Tehran, Iran. J Acute Dis. 2016;5(5):386–392. doi:10.1016/j.joad.2016.08.004
  • Farshadzadeh Z, Hashemi FB, Rahimi S, et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol. 2015;6:1146. doi:10.3389/fmicb.2015.0114626539176